NCAM1 and adenocarcinoma: Although not significantly different, it also appeared that patients with squamous cell NSCLC had elevated ratios of CD3−/CD56+ NK cells and CD3−/NKG2D+ NK cells in general, compared to healthy controls (p = 0.053) and adenocarcinoma patients (Figure 4C).